Index¡¡| About Us ¡¡| Technology Transfer ¡¡| Products ¡¡| Feedback ¡¡| Contact Us ¡¡| ÖĞ ÎÄ¡¡|
ZK-1 Enteric-coated Capsule
ZK-2 Enteric Coated Tablet
ZK-3 Dry Suspensoid
Kurarinone Slow Release Tablet
Prazosin Hydrochloride (USP.29)
Lomerizine Hydrochloride
Sodium Risedronate
Terazosin Hydrochloride( USP30)
Doxazosin Mesylate
Leflunomide
1-bis(4-fluoro phenyl)methyl piperazine
4,4'-Difluorobenzophonone
4,4'-Difluorobenzhydrol
5-Methyl isoxazole-4-carboxylic acid
Thalidomide
 
www.jtsongsheng.com

ZK-5's Sustained Release Preparation £¨Have already patented £©

¡¡¡¡ZK-5 is the third generation product which is studied and used based on the effective composition of the ZK-5 and its derivative. It has already been used in clinical practice for many years, besides making remarkable curative effect in treating the virus hepatitis, it is widely used in each field of clinical for treating many kinds of diseases and liver trauma caused by physics and chemistry factors. ZK-5 is a clinical daily medicine, the existing dosage forms have the ordinary capsule, enteric coated preparation , injection etc. The slow release form of ZK-5 has reduced the number of times of medicine administration, make the density of blood and medicine keep steady within longer time, it not only has overcome the shortcoming of medicine internal fluctuation of the medicine density, but also has facilitated patients.
Recently this product has already applied for the patent for invention.

¡¾Indication¡¿ ¡¡This product is suitable for treating and curing the chronic and acute viral hepatitis which accompany with the glutamatepyruvate transaminase's rising.
Copyright(C)2008,Jintan SongSheng medical and chemical Co.,Ltd All Rights Reserved.
Supported by www.hxchem.net